Evidence map›Paper›PMID 37632035›Full record

ArticleViruses2023

Virus Inactivation by Formaldehyde and Common Lysis Buffers.

Ulrike Seeburg, Lorena Urda, Fabian Otte, Martin J Lett, Silvia Caimi, Christian Mittelholzer, Thomas Klimkait

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ulrike SeeburgMolecular Virology, Department Biomedicine, University of Basel, 4009 Basel, Switzerland.
Lorena UrdaMolecular Virology, Department Biomedicine, University of Basel, 4009 Basel, Switzerland.ORCID 0009-0007-4122-515X
Fabian OtteMolecular Virology, Department Biomedicine, University of Basel, 4009 Basel, Switzerland.ORCID 0000-0003-0572-617X
Martin J LettMolecular Virology, Department Biomedicine, University of Basel, 4009 Basel, Switzerland.
Silvia CaimiMolecular Virology, Department Biomedicine, University of Basel, 4009 Basel, Switzerland.
Christian MittelholzerMolecular Virology, Department Biomedicine, University of Basel, 4009 Basel, Switzerland.ORCID 0000-0003-4353-3555
Thomas KlimkaitMolecular Virology, Department Biomedicine, University of Basel, 4009 Basel, Switzerland.ORCID 0000-0003-4945-6511
University of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous mammalian viruses are routinely analyzed in clinical diagnostic laboratories around the globe or serve as indispensable model systems in viral research. Potentially infectious viral entities are handled as blood, biopsies, or cell and tissue culture samples. Countless protocols describe methods for virus fixation and inactivation, yet for many, a formal proof of safety and completeness of inactivation remains to be shown. While modern nucleic acid extraction methods work quite effectively, data are largely lacking on possible residual viral infectivity, e.g., when assessed after extended culture times, which maximizes the sensitivity for low levels of residual infectiousness. Therefore, we examined the potency and completeness of inactivation procedures on virus-containing specimens when applying commonly used fixatives like formaldehyde or nucleic acid extraction/lysis buffers. Typical representatives of different virus classes, including RNA and DNA viruses, enveloped and non-enveloped, such as adenovirus, enterovirus, lentivirus, and coronavirus, were used, and the reduction in the in vitro infectiousness was assessed for standard protocols. Overall, a 30-minute incubation with formaldehyde at room temperature effectively inactivated all tested enveloped and non-enveloped viruses. Full inactivation of HIV-1 and ECHO-11 was also achieved with all buffers in the test, whereas for SARS-CoV-2 and AdV-5, only five of the seven lysis buffers were fully effective under the tested conditions.

Indexed as

COVID-19Virus InactivationAdenoviridaeAnimalsFormaldehydeMammalsSARS-CoV-2Formaldehydebiosafetyinactivationvirus

Identifiers

PMID37632035
PMCPMC10458352
OpenAlexW4385577542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.